Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.7M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
31.2K
-
Shares change
-
+11.5K
-
Total reported value, excl. options
-
$351K
-
Value change
-
+$130K
-
Number of buys
-
2
-
Price
-
$11.25
Significant Holders of Altimmune, Inc. - Common Stock (ALT) as of Q4 2023
2 filings reported holding ALT - Altimmune, Inc. - Common Stock as of Q4 2023.
Altimmune, Inc. - Common Stock (ALT) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.2K shares
of 80.7M outstanding shares and own 0.04% of the company stock.
Largest 10 shareholders include AMERIPRISE FINANCIAL INC (4.18M shares), BlackRock Inc. (4.04M shares), VANGUARD GROUP INC (3.57M shares), TANG CAPITAL MANAGEMENT LLC (2.75M shares), Nuveen Asset Management, LLC (1.73M shares), Point72 Asset Management, L.P. (1.25M shares), GEODE CAPITAL MANAGEMENT, LLC (1.19M shares), MORGAN STANLEY (1.04M shares), STATE STREET CORP (1.01M shares), and Timelo Investment Management Inc. (809K shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.